News & Events
Showcasing the latest news stories and event headlines from the world of Neurology

From undercooked meat to neuralgic amyotrophy

1920 1080 Michael Furrer, PhD

We have talked to Dr Paolo Ripellino from the Ospedale Civico di Lugano (EOC), Switzerland, about his research on neurological complications related to hepatitis E…

read more

​80-year track record of neurosurgical success

1600 1605 Jared Ou-Young, MSc

The UniversitätsSpital Zürich (USZ) reaches a milestone anniversary in 2017. From humble beginnings to now being one of the top-teaching institutions in Europe, USZ continues to lead…

read more

Impressive results for a new vaccine

1600 1076 Camilla Norrmén, PhD

Experts are enthusiastic about a new shingles vaccine that received FDA approval last month. Shingrix is significantly more effective than the only currently available shingles…

read more

ECTRIMS-ACTRIMS: A conversation with Prof. Till Sprenger

150 150 Lutz Achtnichts, MD

I had the chance to meet up with Professor Sprenger at ECTRIMS-ACTRIMS in Paris last week. We discussed the TEMSO study, which has been evaluating the…

read more

ECTRIMS-ACTRIMS: A conversation with Dr Patricia Mulero

150 150 Lutz Achtnichts, MD

At ECTRIMS-ACTRIMS in Paris, France, I had the chance to sit down with Dr Patricia Mulero to discuss FLOODLIGHT: a prospective pilot study that has…

read more

ECTRIMS-ACTRIMS: A conversation with Dr Tanuja Chitnis

150 150 Lutz Achtnichts, MD

Children and adolescents living with MS face physical and cognitive disability that can severely limit their ability to perform daily activities, such as attending school.…

read more

ECTRIMS-ACTRIMS: Updates to safety of ocrelizumab in pregnancy still “ongoing” after new analysis

898 599 Peter Stevenson, PhD

An update on pregnancy outcomes following ocrelizumab (OCR) treatment in patients with multiple sclerosis (MS) and other autoimmune diseases was delivered at this year’s joint…

read more

ECTRIMS-ACTRIMS: Teriflunomide for multiple sclerosis: is it safe in pregnancy?

898 506 Peter Stevenson, PhD

Friday’s programme at the ECTRIMS-ACTRIMS meeting in Paris played host to an exploration of pregnancy outcomes in multiple sclerosis (MS) patients treated with teriflunomide – …

read more

ECTRIMS-ACTRIMS: Phase III data EXPAND on siponimod for secondary progressive multiple sclerosis

898 506 Peter Stevenson, PhD

Data presented at the recent 7th joint ECTRIMS-ACTRIMS meeting in Paris delved deeper into the efficacy of siponimod in the treatment of secondary progressive MS…

read more

Welcome to Brainwork

899 506 Prof. Dr. Krassen Nedeltchev

Dear colleagues, Thank you for subscribing to BRAINWORK! Your participation has made our eLearning initiative stronger and more wide-ranging! What is Brainwork? Brainwork is a…

read more
welcome-to-brainwork-ectrims-2017

ECTRIMS-ACTRIMS: OBOE study explores biomarkers of neurodegeneration and inflammation in multiple sclerosis

1920 1080 Peter Stevenson, PhD

The development and characterisation of biomarkers in multiple sclerosis (MS) could be a crucial step in understanding disease pathways, as well as the therapeutic mechanisms…

read more
Brainwork-DiabeticDrugMayBenefitHigh-RiskStrokePatients

​Diabetes drug may benefit high-risk stroke patients

4064 2710 Camilla Norrmén, PhD

A study showed last year that the insulin-sensitizing drug pioglitazone reduces the risk for stroke in patients with recent ischemic strokes. A new secondary analysis…

read more
Brainwork is supported by unrestricted grants from: